Skip to main content
SpringerLink
Log in

Mental Health in Chronic and End-Stage Liver Disease

  • Chapter
  • First Online:
Psychosocial Care of End-Stage Organ Disease and Transplant Patients

  • 931 Accesses

Abstract

Patients with chronic liver diseases experience common psychiatric disorders and specific symptoms that have psychiatric and psychological implications. Thus, mental health-care professionals must understand both the inherent liver disease process and the mental health disorders that commonly co-occur with liver diseases. For some types of liver diseases (e.g., Wilson’s disease, hepatic porphyrias), the presenting features may be neuropsychiatric in nature, and clinicians should be aware of the common characteristics of these diseases. Additionally, certain psychiatric disorders are relatively common in patients with liver disease, such as addiction disorders and depression. Specific consideration of the severity of liver disease for pharmacotherapeutic management is required. Patients with liver disease face specific challenges in their daily functioning and with psychological stressors. Interventions tailored to these issues may be most effective. Patients’ complex health-care needs may be best provided through collaborative care models capitalizing on the expertise of multiple disciplines.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Bell BP, Manos MM, Zaman A, Terrault N, Thomas A, Navarro VJ, et al. The epidemiology of newly diagnosed chronic liver disease in gastroenterology practices in the United States: results from population-based surveillance. Am J Gastroenterol. 2008;103(11):2727–36.

    Article  PubMed  Google Scholar 

  2. Davis GL, Albright JE, Cook SF, Rosenberg DM. Projecting future complications of chronic hepatitis C in the United States. Liver Transpl. 2003;9(4):331–8.

    Article  PubMed  Google Scholar 

  3. Goldberg D, Ditah IC, Saeian K, Lalehzari M, Aronsohn A, Gorospe EC, et al. Changes in the prevalence of hepatitis C virus infection, nonalcoholic steatohepatitis, and alcoholic liver disease among patients with cirrhosis or liver failure on the waitlist for liver transplantation. Gastroenterology. 2017;152(5):1090–9.

    Article  PubMed  Google Scholar 

  4. Younossi ZM, Otgonsuren M, Henry L, Venkatesan C, Mishra A, Erario M, et al. Association of nonalcoholic fatty liver disease (NAFLD) with hepatocellular carcinoma (HCC) in the United States from 2004 to 2009. Hepatology. 2015;62(6):1723–30. https://doi.org/10.1002/hep.28123.

    Article  CAS  PubMed  Google Scholar 

  5. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Monograph on cirrhosis. 2014. https://www.niddk.nih.gov/health-information/liver-disease/cirrhosis.

  6. Organ Procurement and Transplantation Network. Data tables. Updated December 15, 2017. https://optn.transplant.hrsa.gov/data/.

  7. Jinjuvadia R, Jinjuvadia C, Puangsricharoen P, Chalasani N, Crabb DW, Liangpunsakul S, et al. Concomitant psychiatric and nonalcohol-related substance use disorders among hospitalized patients with alcoholic liver disease in the United States. Alcohol Clin Exp Res. 2018;42(2):397–402.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Diehl AM. Alcoholic liver disease: natural history. Liver Transpl Surg. 1997;3(3):206–11.

    CAS  PubMed  Google Scholar 

  9. Nielsen JK, Olafsson S, Bergmann OM, Runarsdottir V, Hansdottir I, Sigurdardottir R, et al. Lifetime drinking history in patients with alcoholic liver disease and patients with alcohol use disorder without liver disease. Scand J Gastroenterol. 2017;52(6–7):762–7.

    Article  PubMed  Google Scholar 

  10. DiMartini AF, Beresford TP. Alcoholism and liver transplantation. Curr Opin Organ Transplant. 1999;4(2):177–81.

    Article  Google Scholar 

  11. DiMartini AF, Crone C, Dew MA. Alcohol and substance use in liver transplant patients. Clin Liver Dis. 2011;15(4):727–51.

    Article  PubMed  Google Scholar 

  12. Addolorato G, Mirijello A, Leggio L, Ferrulli A, Landolfi R. Management of alcohol dependence in patients with liver disease. CNS Drugs. 2013;27(4):287–99.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Beresford TP. Predictive factors for alcoholic relapse in the selection of alcohol-dependent persons for hepatic transplant. Liver Transpl Surg. 1997;3(3):280–91.

    Article  CAS  PubMed  Google Scholar 

  14. DiMartini AF, Dew MA, Javed L, Fitzgerald MG, Jain A, Day N. Pretransplant psychiatric and medical comorbidity of alcoholic liver disease patients who received liver transplant. Psychosomatics. 2004;45(6):517–23.

    Article  PubMed  Google Scholar 

  15. DiMartini A, Dew MA, Fitzgerald MG, Fontes P. Clusters of alcohol use disorders diagnostic criteria and predictors of alcohol use after liver transplantation for alcoholic liver disease. Psychosomatics. 2008;49(4):332–40.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Beresford TP, Wongngamnit N, Temple BA. Alcoholism: diagnosis and natural history in the context of medical disease. In: Neuberger J, DiMartini A, editors. Alcohol abuse and liver disease. Oxford: Wiley; 2015. p. 22–34.

    Google Scholar 

  17. Centers for Disease Control and Prevention. Hepatitis C FAQs for health professionals. 2018. https://www.cdc.gov/hepatitis/hcv/hcvfaq.htm#section1.

  18. Centers for Disease Control and Prevention. Hepatitis B FAQs for health professionals. 2018. https://www.cdc.gov/hepatitis/hbv/hbvfaq.htm#overview.

  19. Lok AS, McMahon BJ. Chronic hepatitis B. Hepatology. 2007;45(2):507–39.

    Article  CAS  PubMed  Google Scholar 

  20. Fontana RJ, Hussain KB, Schwartz SM, Moyer CA, Su GL, Lok AS. Emotional distress in chronic hepatitis C patients not receiving antiviral therapy. J Hepatol. 2002;36(3):401–7.

    Article  PubMed  Google Scholar 

  21. Karaivazoglou K, Iconomou G, Triantos C, Hyphantis T, Thomopoulos K, Lagadinou M, et al. Fatigue and depressive symptoms associated with chronic viral hepatitis patients. Health-related quality of life (HRQOL). Ann Hepatol. 2010;9(4):419–27.

    PubMed  Google Scholar 

  22. Modabbernia A, Poustchi H, Malekzadeh R. Neuropsychiatric and psychosocial issues of patients with hepatitis C infection: a selective literature review. Hepat Mon. 2013;13(1):e8340.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Rifai MA, Gleason OC, Sabouni D. Psychiatric care of the patient with hepatitis C: a review of the literature. Prim Care Companion J Clin Psychiatry. 2010;12(6):PCC.09r00877. https://doi.org/10.4088/PCC.09r00877whi.

  24. el-Serag HB, Kunik M, Richardson P, Rabeneck L. Psychiatric disorders among veterans with hepatitis C infection. Gastroenterology. 2002;123(2):476–82.

    Article  PubMed  Google Scholar 

  25. Golden J, O’Dwyer AM, Conroy RM. Depression and anxiety in patients with hepatitis C: prevalence, detection rates and risk factors. Gen Hosp Psychiatry. 2005;27(6):431–8.

    Article  PubMed  Google Scholar 

  26. Ozkan M, Corapcioglu A, Balcioglu I, Ertekin E, Khan S, Ozdemir S, et al. Psychiatric morbidity and its effect on the quality of life of patients with chronic hepatitis B and hepatitis C. Int J Psychiatry Med. 2006;36(3):283–97.

    Article  PubMed  Google Scholar 

  27. Quelhas R, Lopes A. Psychiatric problems in patients infected with hepatitis C before and during antiviral treatment with interferon-alpha: a review. J Psychiatr Pract. 2009;15(4):262–81.

    Article  PubMed  Google Scholar 

  28. Weinstein AA, Kallman Price J, Stepanova M, Poms LW, Fang Y, Moon J, et al. Depression in patients with nonalcoholic fatty liver disease and chronic viral hepatitis B and C. Psychosomatics. 2011;52(2):127–32.

    Article  PubMed  Google Scholar 

  29. Navines R, Castellvi P, Moreno-Espana J, Gimenez D, Udina M, Canizares S, et al. Depressive and anxiety disorders in chronic hepatitis C patients: reliability and validity of the Patient Health Questionnaire. J Affect Disord. 2012;138(3):343–51.

    Article  CAS  PubMed  Google Scholar 

  30. Altindag A, Cadirci D, Sirmatel F. Depression and health related quality of life in non-cirrhotic chronic hepatitis B patients and hepatitis B carriers. Neurosciences (Riyadh). 2009;14(1):56–9.

    Google Scholar 

  31. Modabbernia A, Ashrafi M, Malekzadeh R, Poustchi H. A review of psychosocial issues in patients with chronic hepatitis B. Arch Iran Med. 2013;16(2):114–22.

    PubMed  Google Scholar 

  32. Ashrafi M, Modabbernia A, Dalir M, Taslimi S, Karami M, Ostovaneh MR, et al. Predictors of mental and physical health in non-cirrhotic patients with viral hepatitis: a case control study. J Psychosom Res. 2012;73(3):218–24.

    Article  PubMed  Google Scholar 

  33. Grant BF, Saha TD, Ruan WJ, Goldstein RB, Chou SP, Jung J, et al. Epidemiology of DSM-5 drug use disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions-III. JAMA Psychiat. 2016;73(1):39–47.

    Article  Google Scholar 

  34. Yovtcheva SP, Rifai MA, Moles JK, Van der Linden BJ. Psychiatric comorbidity among hepatitis C-positive patients. Psychosomatics. 2001;42(5):411–5.

    Article  CAS  PubMed  Google Scholar 

  35. Cheung RC. Epidemiology of hepatitis C virus infection in American veterans. Am J Gastroenterol. 2000;95(3):740–7.

    Article  CAS  PubMed  Google Scholar 

  36. Lansky A, Finlayson T, Johnson C, Holtzman D, Wejnert C, Mitsch A, et al. Estimating the number of persons who inject drugs in the United States by meta-analysis to calculate national rates of HIV and hepatitis C virus infections. PLoS One. 2014;9(5):e97596.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  37. Banini BA, Sanyal AJ. Nonalcoholic fatty liver disease: epidemiology, pathogenesis, natural history, diagnosis, and current treatment options. Clin Med Insights Ther. 2016;8:75–84.

    CAS  PubMed  PubMed Central  Google Scholar 

  38. Demir M, Lang S, Steffen HM. Nonalcoholic fatty liver disease—current status and future directions. J Dig Dis. 2015;16(10):541–57.

    Article  CAS  PubMed  Google Scholar 

  39. Noureddin M, Zhang A, Loomba R. Promising therapies for treatment of nonalcoholic steatohepatitis. Expert Opin Emerg Drugs. 2016;21(3):343–57.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Elwing JE, Lustman PJ, Wang HL, Clouse RE. Depression, anxiety, and nonalcoholic steatohepatitis. Psychosom Med. 2006;68(4):563–9.

    Article  PubMed  Google Scholar 

  41. Stewart KE, Levenson JL. Psychological and psychiatric aspects of treatment of obesity and nonalcoholic fatty liver disease. Clin Liver Dis. 2012;16(3):615–29.

    Article  PubMed  PubMed Central  Google Scholar 

  42. Marchesini G, Suppini A, Forlani G. NAFLD treatment: cognitive-behavioral therapy has entered the arena. J Hepatol. 2005;43(6):926–8.

    Article  PubMed  Google Scholar 

  43. Vilstrup H, Amodio P, Bajaj J, Cordoba J, Ferenci P, Mullen KD, et al. Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver. Hepatology. 2014;60(2):715–35.

    Article  PubMed  Google Scholar 

  44. Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei AT. Hepatic encephalopathy—definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology. 2002;35(3):716–21.

    Article  PubMed  Google Scholar 

  45. Bajaj JS, Saeian K, Schubert CM, Hafeezullah M, Franco J, Varma RR, et al. Minimal hepatic encephalopathy is associated with motor vehicle crashes: the reality beyond the driving test. Hepatology. 2009;50(4):1175–83.

    Article  PubMed  Google Scholar 

  46. Bajaj JS, Heuman DM, Sterling RK, Sanyal AJ, Siddiqui M, Matherly S, et al. Validation of EncephalApp, smartphone-based Stroop test, for the diagnosis of covert hepatic encephalopathy. Clin Gastroenterol Hepatol. 2015;13(10):1828–35.

    Article  PubMed  Google Scholar 

  47. Bémeur C, Butterworth RF. Nutrition in the management of cirrhosis and its neurological complications. J Clin Exp Hepatol. 2014;4(2):141–50.

    Article  PubMed  Google Scholar 

  48. Ridley NJ, Draper B, Withall A. Alcohol-related dementia: an update of the evidence. Alzheimers Res Ther. 2013;5(1):3.

    Article  PubMed  PubMed Central  Google Scholar 

  49. Thomson AD, Guerrini I, Marshall EJ. The evolution and treatment of Korsakoff’s syndrome: out of sight, out of mind? Neuropsychol Rev. 2012;22(2):81–92.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  50. Galvin R, Bråthen G, Ivashynka A, Hillbom M, Tanasescu R, Leone MA. EFNS guidelines for diagnosis, therapy and prevention of Wernicke encephalopathy. Eur J Neurol. 2010;17(12):1408–18. https://doi.org/10.1111/j.1468-1331.2010.03153.x.

    Article  CAS  PubMed  Google Scholar 

  51. Dening TR, Berrios GE. Wilson’s disease. Psychiatric symptoms in 195 cases. Arch Gen Psychiatry. 1989;46(12):1126–34.

    Article  CAS  PubMed  Google Scholar 

  52. Levenson JL, editor The American Psychiatric Publishing textbook of psychosomatic medicine: psychiatric care of the medically ill. 2nd ed. Washington, DC: American Psychiatric Publishing; 2011.

    Google Scholar 

  53. Srinivas K, Sinha S, Taly AB, Prashanth LK, Arunodaya GR, Janardhana Reddy YC, et al. Dominant psychiatric manifestations in Wilson’s disease: a diagnostic and therapeutic challenge! J Neurol Sci. 2008;266(1–2):104–8. https://doi.org/10.1016/j.jns.2007.09.009.

    Article  CAS  PubMed  Google Scholar 

  54. Carta M, Mura G, Sorbello O, Farina G, Demelia L. Quality of life and psychiatric symptoms in Wilson’s Disease: the relevance of bipolar disorders. Clin Pract Epidemiol Ment Health. 2012a;8:102–9.

    Article  PubMed  PubMed Central  Google Scholar 

  55. Carta MG, Sorbello O, Moro MF, Bhat KM, Demelia E, Serra A, et al. Bipolar disorders and Wilson’s disease. BMC Psychiatry. 2012b;12:52.

    Article  PubMed  PubMed Central  Google Scholar 

  56. Bandmann O, Weiss KH, Kaler SG. Wilson’s disease and other neurological copper disorders. Lancet Neurol. 2015;14(1):103–13.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  57. Crimlisk HL. The little imitator—porphyria: a neuropsychiatric disorder. J Neurol Neurosurg Psychiatry. 1997;62(4):319–28.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  58. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Porphyria. 2014. https://www.niddk.nih.gov/health-information/liver-disease/porphyria.

  59. Tracy JA, Dyck PJ. Porphyria and its neurologic manifestations. Handb Clin Neurol. 2014;120:839–49.

    Article  PubMed  Google Scholar 

  60. Kessler RC, Bromet EJ. The epidemiology of depression across cultures. Annu Rev Public Health. 2013;34:119–38.

    Article  PubMed  PubMed Central  Google Scholar 

  61. Ewusi-Mensah I, Saunders JB, Williams R. The clinical nature and detection of psychiatric disorders in patients with alcoholic liver disease. Alcohol Alcohol. 1984;19(4):297–302.

    CAS  PubMed  Google Scholar 

  62. Le Strat Y, Le Foll B, Dubertret C. Major depression and suicide attempts in patients with liver disease in the United States. Liver Int. 2015;35(7):1910–6.

    Article  PubMed  Google Scholar 

  63. Mullish BH, Kabir MS, Thursz MR, Dhar A. Review article: depression and the use of antidepressants in patients with chronic liver disease or liver transplantation. Aliment Pharmacol Ther. 2014;40(8):880–92.

    Article  CAS  PubMed  Google Scholar 

  64. Blaxter M, Cyster R. Compliance and risk-taking: the case of alcoholic liver disease. Sociol Health Illn. 1984;6(3):290–310.

    Article  Google Scholar 

  65. Jonas DE, Garbutt JC, Amick HR, Brown JM, Brownley KA, Council CL, et al. Behavioral counseling after screening for alcohol misuse in primary care: a systematic review and meta-analysis for the U.S. Preventive Services Task Force. Ann Intern Med. 2012;157(9):645–54.

    Article  PubMed  Google Scholar 

  66. Weinrieb RM, Van Horn DH, McLellan AT, Volpicelli JR, Calarco JS, Lucey MR. Drinking behavior and motivation for treatment among alcohol-dependent liver transplant candidates. J Addict Dis. 2001;20(2):105–19.

    Article  CAS  PubMed  Google Scholar 

  67. Weinrieb RM, Lucey MR. Treatment of addictive behaviors in liver transplant patients. Liver Transpl. 2007;13(11 Suppl 2):S79–82.

    Article  PubMed  Google Scholar 

  68. Bjornsson E, Olsson J, Rydell A, Fredriksson K, Eriksson C, Sjoberg C, et al. Long-term follow-up of patients with alcoholic liver disease after liver transplantation in Sweden: impact of structured management on recidivism. Scand J Gastroenterol. 2005;40(2):206–16.

    Article  PubMed  Google Scholar 

  69. Burra P, Lucey MR. Liver transplantation in alcoholic patients. Transpl Int. 2005;18(5):491–8.

    Article  PubMed  Google Scholar 

  70. Gedaly R, McHugh PP, Johnston TD, Jeon H, Koch A, Clifford TM, et al. Predictors of relapse to alcohol and illicit drugs after liver transplantation for alcoholic liver disease. Transplantation. 2008;86(8):1090–5.

    Article  PubMed  Google Scholar 

  71. Kodali S, Kaif M, Tariq R, Singal A. Alcohol relapse after liver transplantation for alcoholic cirrhosis—impact on liver graft and patient survival: a meta-analysis. Alcohol Alcohol. 2018;53(2):166-72. https://doi.org/10.1093/alcalc/agx098.

    Article  Google Scholar 

  72. Pessione F, Ramond MJ, Peters L, Pham BN, Batel P, Rueff B, et al. Five-year survival predictive factors in patients with excessive alcohol intake and cirrhosis. Effect of alcoholic hepatitis, smoking and abstinence. Liver Int. 2003;23(1):45–53.

    Article  CAS  PubMed  Google Scholar 

  73. Yates WR, LaBrecque DR, Pfab D. Personality disorder as a contraindication for liver transplantation in alcoholic cirrhosis. Psychosomatics. 1998;39(6):501–11.

    Article  CAS  PubMed  Google Scholar 

  74. Khan A, Tansel A, White DL, Kayani WT, Bano S, Lindsay J, et al. Efficacy of psychosocial interventions in inducing and maintaining alcohol abstinence in patients with chronic liver disease: a systematic review. Clin Gastroenterol Hepatol. 2016;14(2):191–202.e1–4.

    Article  Google Scholar 

  75. Weinrieb RM, Van Horn DH, Lynch KG, Lucey MR. A randomized, controlled study of treatment for alcohol dependence in patients awaiting liver transplantation. Liver Transpl. 2011;17(5):539–47.

    Article  PubMed  Google Scholar 

  76. Moriarty KJ, Platt H, Crompton S, Darling W, Blakemore M, Hutchinson S, et al. Collaborative care for alcohol-related liver disease. Clin Med (Lond). 2007;7(2):125–8.

    Article  Google Scholar 

  77. DiMartini AF, Dew MA. Monitoring alcohol use on the liver transplant wait list: therapeutic and practical issues. Liver Transpl. 2012;18(11):1267–9.

    Article  PubMed  Google Scholar 

  78. Crowley P. Long-term drug treatment of patients with alcohol dependence. Aust Prescr. 2015;38(2):41–3.

    Article  PubMed  PubMed Central  Google Scholar 

  79. Falk DE, Yi HY, Hiller-Sturmhofel S. An epidemiologic analysis of co-occurring alcohol and tobacco use and disorders: findings from the National Epidemiologic Survey on Alcohol and Related Conditions. Alcohol Res Health. 2006;29(3):162–71.

    PubMed  PubMed Central  Google Scholar 

  80. Bataller R. Time to ban smoking in patients with chronic liver diseases. Hepatology. 2006;44(6):1394–6.

    Article  PubMed  CAS  Google Scholar 

  81. Kolly P, Knopfli M, Dufour JF. Effect of smoking on survival of patients with hepatocellular carcinoma. Liver Int. 2017;37(11):1682–7.

    Article  PubMed  Google Scholar 

  82. Bentzley BS, Barth KS, Back SE, Book SW. Discontinuation of buprenorphine maintenance therapy: perspectives and outcomes. J Subst Abus Treat. 2015;52:48–57.

    Article  Google Scholar 

  83. Koch M, Banys P. Liver transplantation and opioid dependence. JAMA. 2001;285(8):1056–8.

    Article  CAS  PubMed  Google Scholar 

  84. Parfieniuk A, Flisiak R. Role of cannabinoids in chronic liver diseases. World J Gastroenterol. 2008;14(40):6109–14.

    Article  PubMed  PubMed Central  Google Scholar 

  85. Patsenker E, Stickel F. Cannabinoids in liver diseases. Clin Liver Dis. 2016;7(2):21–5.

    Article  Google Scholar 

  86. Hézode C, Zafrani ES, Roudot-Thoraval F, Costentin C, Hessami A, Bouvier-Alias M, et al. Daily cannabis use: a novel risk factor of steatosis severity in patients with chronic hepatitis C. Gastroenterology. 2008;134(2):432–9.

    Article  PubMed  Google Scholar 

  87. Ishida JH, Peters MG, Jin C, Louie K, Tan V, Bacchetti P, et al. Influence of cannabis use on severity of hepatitis C disease. Clin Gastroenterol Hepatol. 2008;6(1):69–75.

    Article  PubMed  PubMed Central  Google Scholar 

  88. Tam J, Liu J, Mukhopadhyay B, Cinar R, Godlewski G, Kunos G. Endocannabinoids in liver disease. Hepatology. 2011;53(1):346–55.

    Article  CAS  PubMed  Google Scholar 

  89. Adejumo AC, Alliu S, Ajayi TO, Adejumo KL, Adegbala OM, Onyeakusi NE, et al. Cannabis use is associated with reduced prevalence of non-alcoholic fatty liver disease: a cross-sectional study. PLoS One. 2017;12(4):e0176416.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  90. Brunet L, Moodie EE, Rollet K, Cooper C, Walmsley S, Potter M, et al. Marijuana smoking does not accelerate progression of liver disease in HIV-hepatitis C coinfection: a longitudinal cohort analysis. Clin Infect Dis. 2013;57(5):663–70.

    Article  PubMed  PubMed Central  Google Scholar 

  91. Magen I, Avraham Y, Berry E, Mechoulam R. Endocannabinoids in liver disease and hepatic encephalopathy. Curr Pharm Des. 2008;14(23):2362–9.

    Article  CAS  PubMed  Google Scholar 

  92. Schrot RJ, Hubbard JR. Cannabinoids: Medical implications. Ann Med. 2016;48(3):128–41.

    Article  CAS  PubMed  Google Scholar 

  93. Wilkinson ST, D’Souza DC. Problems with the medicalization of marijuana. JAMA. 2014;311(23):2377–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  94. Rogal SS, Bielefeldt K, Wasan AD, Lotrich FE, Zickmund S, Szigethy E, et al. Inflammation, psychiatric symptoms, and opioid use are associated with pain and disability in patients with cirrhosis. Clin Gastroenterol Hepatol. 2015;13(5):1009–16.

    Article  PubMed  Google Scholar 

  95. Silberbogen AK, Janke EA, Hebenstreit C. A closer look at pain and hepatitis C: preliminary data from a veteran population. J Rehabil Res Dev. 2007;44(2):231–44.

    Article  PubMed  Google Scholar 

  96. Whitehead AJ, Dobscha SK, Morasco BJ, Ruimy S, Bussell C, Hauser P. Pain, substance use disorders and opioid analgesic prescription patterns in veterans with hepatitis C. J Pain Symptom Manag. 2008;36(1):39–45.

    Article  Google Scholar 

  97. Imani F, Motavaf M, Safari S, Alavian SM. The therapeutic use of analgesics in patients with liver cirrhosis: a literature review and evidence-based recommendations. Hepat Mon. 2014;14(10):e23539.

    Article  PubMed  PubMed Central  Google Scholar 

  98. Rogal SS, Bielefeldt K, Wasan AD, Szigethy E, Lotrich F, DiMartini AF. Fibromyalgia symptoms and cirrhosis. Dig Dis Sci. 2015b;60(5):1482–9.

    Article  CAS  PubMed  Google Scholar 

  99. Riley TR 3rd, Koch K. Characteristics of upper abdominal pain in those with chronic liver disease. Dig Dis Sci. 2003;48(10):1914–8.

    Article  PubMed  Google Scholar 

  100. Rogal SS, Winger D, Bielefeldt K, Szigethy E. Pain and opioid use in chronic liver disease. Dig Dis Sci. 2013;58(10):2976–85.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  101. Fouad YM, Makhlouf MM, Khalaf H, Mostafa Z, Abdel Raheem E, Meneasi W. Is irritable bowel syndrome associated with chronic hepatitis C? J Gastroenterol Hepatol. 2010;25(7):1285–8.

    Article  PubMed  Google Scholar 

  102. Dirchwolf M, Ruf AE. Role of systemic inflammation in cirrhosis: from pathogenesis to prognosis. World J Hepatol. 2015;7(16):1974–81.

    Article  PubMed  PubMed Central  Google Scholar 

  103. Acharya C, Betrapally NS, Gillevet PM, Sterling RK, Akbarali H, White MB, et al. Chronic opioid use is associated with altered gut microbiota and predicts readmissions in patients with cirrhosis. Aliment Pharmacol Ther. 2017;45(2):319–31.

    Article  CAS  PubMed  Google Scholar 

  104. Randall HB, Alhamad T, Schnitzler MA, Zhang Z, Ford-Glanton S, Axelrod DA, et al. Survival implications of opioid use before and after liver transplantation. Liver Transpl. 2017;23(3):305–14.

    Article  PubMed  Google Scholar 

  105. Adedoyin A, Branch RA. Pharmacokinetics. In: Zakim D, Boyer TD, editors. Hepatology: a textbook of liver disease. 3rd ed. Philadelphia: WB Saunders; 1996. p. 307–22.

    Google Scholar 

  106. Blaschke TF. Protein binding and kinetics of drugs in liver diseases. Clin Pharmacokinet. 1977;2(1):32–44.

    Article  CAS  PubMed  Google Scholar 

  107. DeSanty KP, Amabile CM. Antidepressant-induced liver injury. Ann Pharmacother. 2007;41(7):1201–11.

    Article  CAS  PubMed  Google Scholar 

  108. Russo MW, Watkins PB. Are patients with elevated liver tests at increased risk of drug-induced liver injury? Gastroenterology. 2004;126(5):1477–80.

    Article  PubMed  Google Scholar 

  109. Bailey DE Jr, Hendrix CC, Steinhauser KE, Stechuchak KM, Porter LS, Hudson J, et al. Randomized trial of an uncertainty self-management telephone intervention for patients awaiting liver transplant. Patient Educ Couns. 2017;100(3):509–17.

    Article  PubMed  Google Scholar 

  110. Singh N, Gayowski T, Wagener MM, Marino IR. Depression in patients with cirrhosis. Impact on outcome. Dig Dis Sci. 1997;42(7):1421–7.

    Article  CAS  PubMed  Google Scholar 

  111. Engle D. Psychosocial aspects of the organ transplant experience: what has been established and what we need for the future. J Clin Psychol. 2001;57(4):521–49.

    Article  CAS  PubMed  Google Scholar 

  112. Olbrisch ME, Benedict SM, Ashe K, Levenson JL. Psychological assessment and care of organ transplant patients. J Consult Clin Psychol. 2002;70(3):771–83.

    Article  PubMed  Google Scholar 

  113. Corbett C, Armstrong MJ, Parker R, Webb K, Neuberger JM. Mental health disorders and solid-organ transplant recipients. Transplantation. 2013;96(7):593–600.

    Article  PubMed  Google Scholar 

  114. Rogal SS, Dew MA, Fontes P, DiMartini AF. Early treatment of depressive symptoms and long-term survival after liver transplantation. Am J Transplant. 2013;13(4):928–35.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  115. Stewart BJ, Turnbull D, Mikocka-Walus AA, Harley HA, Andrews JM. Acceptability of psychotherapy, pharmacotherapy, and self-directed therapies in Australians living with chronic hepatitis C. J Clin Psychol Med Settings. 2013;20(4):427–39.

    Article  PubMed  Google Scholar 

  116. Bajaj JS, Ellwood M, Ainger T, Burroughs T, Fagan A, Gavis EA, et al. Mindfulness-based stress reduction therapy improves patient and caregiver-reported outcomes in cirrhosis. Clin Transl Gastroenterol. 2017;8(7):e108.

    Article  PubMed  PubMed Central  Google Scholar 

  117. Evon DM, Simpson K, Kixmiller S, Galanko J, Dougherty K, Golin C, et al. A randomized controlled trial of an integrated care intervention to increase eligibility for chronic hepatitis C treatment. Am J Gastroenterol. 2011;106(10):1777–86. https://doi.org/10.1038/ajg.2011.219.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  118. Morana JG. Psychological evaluation and follow-up in liver transplantation. World J Gastroenterol. 2009;15(6):694–6.

    Article  PubMed  PubMed Central  Google Scholar 

  119. Neri S, Bertino G, Petralia A, Giancarlo C, Rizzotto A, Calvagno GS, et al. A multidisciplinary therapeutic approach for reducing the risk of psychiatric side effects in patients with chronic hepatitis C treated with pegylated interferon alpha and ribavirin. J Clin Gastroenterol. 2010;44(9):e210–7. https://doi.org/10.1097/MCG.0b013e3181d88af5.

    Article  CAS  PubMed  Google Scholar 

  120. Sharif F, Mohebbi S, Tabatabaee HR, Saberi-Firoozi M, Gholamzadeh S. Effects of psycho-educational intervention on health-related quality of life (QOL) of patients with chronic liver disease referring to Shiraz University of Medical Sciences. Health Qual Life Outcomes. 2005;3:81.

    Article  PubMed  PubMed Central  Google Scholar 

  121. Rizzo M, Creed F, Goldberg D, Meader N, Pilling S. A systematic review of non-pharmacological treatments for depression in people with chronic physical health problems. J Psychosom Res. 2011;71(1):18–27.

    Article  PubMed  Google Scholar 

  122. Grover S, Sarkar S. Liver transplant-psychiatric and psychosocial aspects. J Clin Exp Hepatol. 2012;2(4):382–92.

    Article  PubMed  PubMed Central  Google Scholar 

  123. Gross CR, Kreitzer MJ, Thomas W, Reilly-Spong M, Cramer-Bornemann M, Nyman JA, et al. Mindfulness-based stress reduction for solid organ transplant recipients: a randomized controlled trial. Altern Ther Health Med. 2010;16(5):30–8.

    PubMed  PubMed Central  Google Scholar 

  124. Larson AM, Curtis JR. Integrating palliative care for liver transplant candidates: “too well for transplant, too sick for life”. JAMA. 2006;295(18):2168–76.

    Article  CAS  PubMed  Google Scholar 

  125. Wright L, Pape D, Ross K, Campbell M, Bowman K. Approaching end-of-life care in organ transplantation: the impact of transplant patients’ death and dying. Prog Transplant. 2007;17(1):57–61.

    Article  PubMed  Google Scholar 

  126. Baumann AJ, Wheeler DS, James M, Turner R, Siegel A, Navarro VJ. Benefit of early palliative care intervention in end-stage liver disease patients awaiting liver transplantation. J Pain Symptom Manag. 2015;50(6):882–6.

    Article  Google Scholar 

  127. Lamba S, Murphy P, McVicker S, Harris Smith J, Mosenthal AC. Changing end-of-life care practice for liver transplant service patients: structured palliative care intervention in the surgical intensive care unit. J Pain Symptom Manag. 2012;44(4):508–19.

    Article  Google Scholar 

  128. Katon WJ, Lin EH, Von Korff M, Ciechanowski P, Ludman EJ, Young B, et al. Collaborative care for patients with depression and chronic illnesses. N Engl J Med. 2010;363(27):2611–20.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Psychiatry, University of North Carolina Hospitals, Chapel Hill, NC, USA

    Rebekah Nash

  2. Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA, USA

    Eric Golden

  3. Departments of Psychiatry, Psychology, Epidemiology, Biostatistics and the Clinical and Translational Science Institute, University of Pittsburgh, Pittsburgh, PA, USA

    Mary Amanda Dew

  4. Departments of Psychiatry and Surgery and the Clinical and Translational Science Institute, University of Pittsburgh, Pittsburgh, PA, USA

    Andrea F. DiMartini

Authors
  1. Rebekah Nash
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Eric Golden
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mary Amanda Dew
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Andrea F. DiMartini
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mary Amanda Dew .

Editor information

Editors and Affiliations

  1. Stanford University School of Medicine, Stanford, CA, USA

    Yelizaveta Sher

  2. Stanford University School of Medicine, Stanford, CA, USA

    José R. Maldonado

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Nash, R., Golden, E., Dew, M.A., DiMartini, A.F. (2019). Mental Health in Chronic and End-Stage Liver Disease. In: Sher, Y., Maldonado, J. (eds) Psychosocial Care of End-Stage Organ Disease and Transplant Patients. Springer, Cham. https://doi.org/10.1007/978-3-319-94914-7_12

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-94914-7_12

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-94913-0

  • Online ISBN: 978-3-319-94914-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation